{"id":359768,"date":"2025-08-30T10:58:39","date_gmt":"2025-08-30T10:58:39","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-artivion\/"},"modified":"2025-08-30T10:58:39","modified_gmt":"2025-08-30T10:58:39","slug":"how-to-buy-artivion","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/","title":{"rendered":"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-359768","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Artivion, Inc. (AORT) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. G\u00fcncel hisse performans\u0131, risk analizi ve 2025 i\u00e7in ad\u0131m ad\u0131m ticaret stratejilerini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Artivion, Inc. (AORT) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. G\u00fcncel hisse performans\u0131, risk analizi ve 2025 i\u00e7in ad\u0131m ad\u0131m ticaret stratejilerini ke\u015ffedin."},"intro":"Kalp cerrahisinde ses getiren bir medikal cihaz \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Artivion, Inc. (AORT), son teknoloji ile g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyelini birle\u015ftiriyor\u2014geleneksel sa\u011fl\u0131k hisselerinin \u00f6tesine bakmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Yenilik\u00e7i aort \u00e7\u00f6z\u00fcmleri ve etkileyici son kazan\u00e7lar\u0131yla, bu \u015firket geni\u015fleyen medikal cihaz pazar\u0131na eri\u015fmek i\u00e7in benzersiz bir f\u0131rsat sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kalp cerrahisinde ses getiren bir medikal cihaz \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Artivion, Inc. (AORT), son teknoloji ile g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyelini birle\u015ftiriyor\u2014geleneksel sa\u011fl\u0131k hisselerinin \u00f6tesine bakmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Yenilik\u00e7i aort \u00e7\u00f6z\u00fcmleri ve etkileyici son kazan\u00e7lar\u0131yla, bu \u015firket geni\u015fleyen medikal cihaz pazar\u0131na eri\u015fmek i\u00e7in benzersiz bir f\u0131rsat sunuyor."},"body_html":"<h2>\ud83d\udcc8 Artivion Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>30 A\u011fustos 2025 itibar\u0131yla, Artivion, Inc. (AORT) NYSE'de <strong>43,80 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014Artivion'un bir sonraki \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 tarih. Tarihsel olarak, bu raporlar fiyatlar\u0131 dramatik \u015fekilde hareket ettirdi.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 AORT Hissesini Nas\u0131l Etkiler?<\/h3> <p>7 A\u011fustos 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131 oyunun kurallar\u0131n\u0131 de\u011fi\u015ftirdi. Hisse, ola\u011fan\u00fcst\u00fc 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131n ard\u0131ndan A\u011fustos ba\u015f\u0131nda yakla\u015f\u0131k <strong>32 $'dan 41 $'\u0131n \u00fczerine<\/strong> f\u0131rlad\u0131. Bu, bir\u00e7ok yat\u0131r\u0131mc\u0131y\u0131 \u015fa\u015f\u0131rtan devasa bir <strong>%25'ten fazla tek g\u00fcnl\u00fck kazan\u00e7<\/strong> anlam\u0131na geliyor.<\/p> <p>Son kazan\u00e7 desenlerine bak\u0131ld\u0131\u011f\u0131nda:<\/p> <ul> <li><strong>7 A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131, 0,24 $ EPS vs. 0,11 $ tahmin \u2192 <strong>%25 fiyat art\u0131\u015f\u0131<\/strong><\/li> <li><strong>May\u0131s 2025<\/strong>: \u00d6nceki kazan\u00e7lar istikrarl\u0131 b\u00fcy\u00fcme g\u00f6sterdi ancak daha az dramatik hareket<\/li> <li><strong>\u015eubat 2025<\/strong>: Sa\u011flam performans ancak daha geni\u015f piyasa ko\u015fullar\u0131 taraf\u0131ndan g\u00f6lgede b\u0131rak\u0131ld\u0131<\/li> <\/ul> <p>Desen a\u00e7\u0131k: Artivion kazan\u00e7 beklentilerini \u00f6nemli \u00f6l\u00e7\u00fcde a\u015ft\u0131\u011f\u0131nda, hisse patlay\u0131c\u0131 yukar\u0131 y\u00f6nl\u00fc momentumla tepki verir. Bu da 6 Kas\u0131m tarihini hem mevcut hissedarlar hem de potansiyel al\u0131c\u0131lar i\u00e7in \u00f6zellikle \u00f6nemli k\u0131lar.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3> <p>Artivion hisseleri son alt\u0131 ayda <strong>%36'dan fazla etkileyici bir getiri<\/strong> sa\u011flad\u0131:<\/p> <p><strong>Mart 2025<\/strong>: Yakla\u015f\u0131k 32 $ (k\u0131\u015f konsolidasyon sonras\u0131)<br\/> <strong>Nisan 2025<\/strong>: Yat\u0131r\u0131mc\u0131 g\u00fcveninin artmas\u0131yla kademeli y\u00fckseli\u015f 35 $<br\/> <strong>May\u0131s 2025<\/strong>: G\u00fc\u00e7l\u00fc \u00e7eyrek sonu\u00e7 beklentisiyle 38 $'a ula\u015ft\u0131<br\/> <strong>Haziran 2025<\/strong>: Piyasa volatilitesi nedeniyle ge\u00e7ici geri \u00e7ekilme 34 $<br\/> <strong>Temmuz 2025<\/strong>: Teknik destekle istikrarl\u0131 toparlanma 37 $<br\/> <strong>A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7 kataliz\u00f6r\u00fcyle patlay\u0131c\u0131 b\u00fcy\u00fcme 43,80 $<\/p> <p>Bu yukar\u0131 y\u00f6nl\u00fc seyir birka\u00e7 \u00f6nemli fakt\u00f6r\u00fc yans\u0131t\u0131yor:<\/p> <ul> <li>Kalp medikal cihazlar\u0131na g\u00fc\u00e7l\u00fc talep<\/li> <li>\u00d6nceki siber g\u00fcvenlik zorluklar\u0131ndan ba\u015far\u0131l\u0131 toparlanma<\/li> <li>\u0130yile\u015fen sa\u011fl\u0131k harcamas\u0131 trendleri<\/li> <li>Pazar eri\u015fimini geni\u015fleten stratejik ortakl\u0131klar<\/li> <\/ul> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket performans\u0131na dayanarak, beklenenler \u015funlar:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 45-48 $ aral\u0131\u011f\u0131 (g\u00fc\u00e7l\u00fc kazan\u00e7lardan devam eden momentum)<br\/> <strong>2026 Projeksiyonu<\/strong>: 52-58 $ (pazar geni\u015flemesi ve yeni \u00fcr\u00fcn lansmanlar\u0131)<br\/> <strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 65-75 $ (yerle\u015fik pazar liderli\u011fi pozisyonu)<br\/> <strong>2030 Vizyonu<\/strong>: 85-100+ $ (k\u00fcresel sa\u011fl\u0131k altyap\u0131s\u0131 b\u00fcy\u00fcmesi)<\/p> <p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Yenilik\u00e7i teknoloji, artan pazar talebi ve g\u00fc\u00e7l\u00fc finansal performans\u0131n birle\u015fimi cazip bir yat\u0131r\u0131m f\u0131rsat\u0131 yarat\u0131yor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onay s\u00fcre\u00e7leri \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir<\/li> <li><strong>Y\u00fcksek volatilite<\/strong>: %8 haftal\u0131k dalgalanmalar g\u00fc\u00e7l\u00fc risk y\u00f6netimi gerektirir<\/li> <li><strong>K\u00e2rl\u0131l\u0131k zorluklar\u0131<\/strong>: Gelir art\u0131\u015f\u0131na ra\u011fmen negatif EBIT marjlar\u0131<\/li> <li><strong>Rekabet bask\u0131s\u0131<\/strong>: Daha b\u00fcy\u00fck medikal cihaz \u015firketlerinin benzer pazarlara girmesi<\/li> <li><strong>Bor\u00e7 seviyeleri<\/strong>: 1,23 toplam bor\u00e7\/\u00f6zsermaye oran\u0131 izlenmeli<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Kazan\u00e7 patlamas\u0131<\/strong>: 2. \u00e7eyrek EPS 0,24 $, tahminleri %118 a\u015ft\u0131<\/li> <li><strong>Gelir b\u00fcy\u00fcmesi<\/strong>: Y\u0131ll\u0131k %15 art\u0131\u015fla 113 milyon $<\/li> <li><strong>Stratejik ortakl\u0131klar<\/strong>: NEXUS cihaz\u0131 i\u00e7in Endospan ile 25 milyon $ finansman anla\u015fmas\u0131<\/li> <li><strong>Sekt\u00f6r trendi<\/strong>: Kalp cihazlar\u0131 pazar\u0131 y\u0131ll\u0131k %7 b\u00fcy\u00fcyor<\/li> <li><strong>Teknik momentum<\/strong>: 5 May\u0131s 2025'te Alt\u0131n Y\u0131ld\u0131z Sinyali ger\u00e7ekle\u015fti<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Rahat oldu\u011funuz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcyle ba\u015flay\u0131n\u20141-2 hisse bile ba\u015flang\u0131\u00e7 i\u00e7in yeterlidir<\/li> <li><strong>6 Kas\u0131m'\u0131 izleyin<\/strong>: Kazan\u00e7 a\u00e7\u0131klamas\u0131 i\u00e7in uyar\u0131lar kurun ve olas\u0131 volatiliteye haz\u0131rl\u0131kl\u0131 olun<\/li> <li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin<\/strong>: AORT'u dengeli bir portf\u00f6y\u00fcn par\u00e7as\u0131 olarak tutun, t\u00fcm stratejiniz yapmay\u0131n<\/li> <li><strong>S\u00fcrekli \u00f6\u011frenin<\/strong>: Medikal cihaz sekt\u00f6r\u00fc trendlerini ve reg\u00fclasyon geli\u015fmelerini takip edin<\/li> <\/ol> <p>Esprili t\u00fcccar bilgeli\u011fi: \"AORT ticareti kalp cerrahisi gibidir\u2014h\u0131zdan \u00e7ok hassasiyet \u00f6nemlidir. Kimse portf\u00f6y\u00fcnde '\u00fc\u00e7l\u00fc baypas' istemez!\"<\/p> <h2>\u2705 Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table border=\"1\" cellpadding=\"5\" cellspacing=\"0\"> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NYSE listeli hisseleri sunan ve makul \u00fccretlere sahip oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform g\u00fcvenlik i\u00e7in kimlik do\u011frulamas\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Risk almaya rahat oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"AORT\" aramas\u0131 yap\u0131n<\/td><td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fcz\u00fc belirleyin<\/td><td>Limit emirleri giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmenize yard\u0131mc\u0131 olur<\/td><\/tr> <tr><td>6<\/td><td>G\u00f6zden ge\u00e7irin ve onaylay\u0131n<\/td><td>Hisse miktar\u0131 ve sipari\u015f detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonunuzu izleyin<\/td><td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, Artivion gibi hisselere eri\u015fimi daha ula\u015f\u0131labilir k\u0131lan birka\u00e7 avantaj sunar:<\/p> <p><strong>Sadece 5 $ minimum depozito<\/strong>\u2014daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce stratejileri minimal riskle test edebilirsiniz. Bu, AORT gibi haftal\u0131k %8 dalgalanma ya\u015fayabilen volatil hisselerde \u00f6zellikle de\u011ferlidir.<\/p> <p><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong>\u2014genellikle tek bir belge ile dakikalar i\u00e7inde tamamlan\u0131r. Bu sayede piyasa f\u0131rsatlar\u0131na h\u0131zl\u0131ca yan\u0131t verebilirsiniz, uzun hesap a\u00e7ma gecikmeleri olmaz.<\/p> <p><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong>\u2014kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100'den fazla y\u00f6ntem. Bu esneklik, k\u00e2rlar\u0131n\u0131z\u0131 size en uygun \u015fekilde \u00e7ekmenizi sa\u011flar.<\/p> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, karma\u015f\u0131k ticaret yaz\u0131l\u0131mlar\u0131nda gezinmek yerine piyasa dinamiklerini \u00f6\u011frenmeye odaklanmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Artivion: Kalp Yenili\u011finde Lider<\/h2> <p>Artivion, kalp ve damar cerrahisi teknolojilerine odaklanan uzmanla\u015fm\u0131\u015f bir medikal cihaz \u015firketidir. \u015eirket, aort hastal\u0131klar\u0131 tedavisinde benzersiz bir ni\u015f olu\u015fturmu\u015f, d\u00fcnya \u00e7ap\u0131nda tan\u0131nan cerrahlarla i\u015f birli\u011fi yaparak hayat de\u011fi\u015ftiren teknolojiler geli\u015ftirmi\u015ftir.<\/p> <p>\u015eirketin \u00fcr\u00fcn portf\u00f6y\u00fc d\u00f6rt ana kategoriyi i\u00e7erir:<\/p> <ul> <li><strong>Karma\u015f\u0131k damar onar\u0131mlar\u0131 i\u00e7in aort stent greftleri<\/strong><\/li> <li><strong>Azalt\u0131lm\u0131\u015f antikoag\u00fclasyon gereksinimli On-X mekanik kalp kapaklar\u0131<\/strong><\/li> <li><strong>Geli\u015fmi\u015f cerrahi sonu\u00e7lar i\u00e7in BioGlue gibi cerrahi s\u0131zd\u0131rmazl\u0131k malzemeleri<\/strong><\/li> <li><strong>Kalp rekonstr\u00fcksiyonu i\u00e7in implantabl insan dokular\u0131<\/strong><\/li> <\/ul> <p>Yakla\u015f\u0131k 2,07 milyar $ piyasa de\u011feri ile Artivion, klinik veriler, g\u00fc\u00e7l\u00fc cerrah ili\u015fkileri ve geli\u015fmekte olan pazarlardaki uygulama ile daha b\u00fcy\u00fck medikal cihaz firmalar\u0131na kar\u015f\u0131 rekabet etmektedir.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Artivion'un On-X mekanik kalp kapa\u011f\u0131, klinik faydalar\u0131 o kadar \u00f6nemli g\u00f6sterdi ki, sadece ABD'de tahmini 100 milyon $ geni\u015fleme f\u0131rsat\u0131 a\u00e7t\u0131\u2014bunun nedeni, deneme verilerinin hastalar i\u00e7in b\u00fcy\u00fck kanama riskini azaltt\u0131\u011f\u0131n\u0131 g\u00f6stermesiydi.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Artivion Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>30 A\u011fustos 2025 itibar\u0131yla, Artivion, Inc. (AORT) NYSE&#8217;de <strong>43,80 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014Artivion&#8217;un bir sonraki \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 tarih. Tarihsel olarak, bu raporlar fiyatlar\u0131 dramatik \u015fekilde hareket ettirdi.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 AORT Hissesini Nas\u0131l Etkiler?<\/h3>\n<p>7 A\u011fustos 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131 oyunun kurallar\u0131n\u0131 de\u011fi\u015ftirdi. Hisse, ola\u011fan\u00fcst\u00fc 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131n ard\u0131ndan A\u011fustos ba\u015f\u0131nda yakla\u015f\u0131k <strong>32 $&#8217;dan 41 $&#8217;\u0131n \u00fczerine<\/strong> f\u0131rlad\u0131. Bu, bir\u00e7ok yat\u0131r\u0131mc\u0131y\u0131 \u015fa\u015f\u0131rtan devasa bir <strong>%25&#8217;ten fazla tek g\u00fcnl\u00fck kazan\u00e7<\/strong> anlam\u0131na geliyor.<\/p>\n<p>Son kazan\u00e7 desenlerine bak\u0131ld\u0131\u011f\u0131nda:<\/p>\n<ul>\n<li><strong>7 A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131, 0,24 $ EPS vs. 0,11 $ tahmin \u2192 <strong>%25 fiyat art\u0131\u015f\u0131<\/strong><\/li>\n<li><strong>May\u0131s 2025<\/strong>: \u00d6nceki kazan\u00e7lar istikrarl\u0131 b\u00fcy\u00fcme g\u00f6sterdi ancak daha az dramatik hareket<\/li>\n<li><strong>\u015eubat 2025<\/strong>: Sa\u011flam performans ancak daha geni\u015f piyasa ko\u015fullar\u0131 taraf\u0131ndan g\u00f6lgede b\u0131rak\u0131ld\u0131<\/li>\n<\/ul>\n<p>Desen a\u00e7\u0131k: Artivion kazan\u00e7 beklentilerini \u00f6nemli \u00f6l\u00e7\u00fcde a\u015ft\u0131\u011f\u0131nda, hisse patlay\u0131c\u0131 yukar\u0131 y\u00f6nl\u00fc momentumla tepki verir. Bu da 6 Kas\u0131m tarihini hem mevcut hissedarlar hem de potansiyel al\u0131c\u0131lar i\u00e7in \u00f6zellikle \u00f6nemli k\u0131lar.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3>\n<p>Artivion hisseleri son alt\u0131 ayda <strong>%36&#8217;dan fazla etkileyici bir getiri<\/strong> sa\u011flad\u0131:<\/p>\n<p><strong>Mart 2025<\/strong>: Yakla\u015f\u0131k 32 $ (k\u0131\u015f konsolidasyon sonras\u0131)<br \/> <strong>Nisan 2025<\/strong>: Yat\u0131r\u0131mc\u0131 g\u00fcveninin artmas\u0131yla kademeli y\u00fckseli\u015f 35 $<br \/> <strong>May\u0131s 2025<\/strong>: G\u00fc\u00e7l\u00fc \u00e7eyrek sonu\u00e7 beklentisiyle 38 $&#8217;a ula\u015ft\u0131<br \/> <strong>Haziran 2025<\/strong>: Piyasa volatilitesi nedeniyle ge\u00e7ici geri \u00e7ekilme 34 $<br \/> <strong>Temmuz 2025<\/strong>: Teknik destekle istikrarl\u0131 toparlanma 37 $<br \/> <strong>A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7 kataliz\u00f6r\u00fcyle patlay\u0131c\u0131 b\u00fcy\u00fcme 43,80 $<\/p>\n<p>Bu yukar\u0131 y\u00f6nl\u00fc seyir birka\u00e7 \u00f6nemli fakt\u00f6r\u00fc yans\u0131t\u0131yor:<\/p>\n<ul>\n<li>Kalp medikal cihazlar\u0131na g\u00fc\u00e7l\u00fc talep<\/li>\n<li>\u00d6nceki siber g\u00fcvenlik zorluklar\u0131ndan ba\u015far\u0131l\u0131 toparlanma<\/li>\n<li>\u0130yile\u015fen sa\u011fl\u0131k harcamas\u0131 trendleri<\/li>\n<li>Pazar eri\u015fimini geni\u015fleten stratejik ortakl\u0131klar<\/li>\n<\/ul>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket performans\u0131na dayanarak, beklenenler \u015funlar:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 45-48 $ aral\u0131\u011f\u0131 (g\u00fc\u00e7l\u00fc kazan\u00e7lardan devam eden momentum)<br \/> <strong>2026 Projeksiyonu<\/strong>: 52-58 $ (pazar geni\u015flemesi ve yeni \u00fcr\u00fcn lansmanlar\u0131)<br \/> <strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 65-75 $ (yerle\u015fik pazar liderli\u011fi pozisyonu)<br \/> <strong>2030 Vizyonu<\/strong>: 85-100+ $ (k\u00fcresel sa\u011fl\u0131k altyap\u0131s\u0131 b\u00fcy\u00fcmesi)<\/p>\n<p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Yenilik\u00e7i teknoloji, artan pazar talebi ve g\u00fc\u00e7l\u00fc finansal performans\u0131n birle\u015fimi cazip bir yat\u0131r\u0131m f\u0131rsat\u0131 yarat\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onay s\u00fcre\u00e7leri \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir<\/li>\n<li><strong>Y\u00fcksek volatilite<\/strong>: %8 haftal\u0131k dalgalanmalar g\u00fc\u00e7l\u00fc risk y\u00f6netimi gerektirir<\/li>\n<li><strong>K\u00e2rl\u0131l\u0131k zorluklar\u0131<\/strong>: Gelir art\u0131\u015f\u0131na ra\u011fmen negatif EBIT marjlar\u0131<\/li>\n<li><strong>Rekabet bask\u0131s\u0131<\/strong>: Daha b\u00fcy\u00fck medikal cihaz \u015firketlerinin benzer pazarlara girmesi<\/li>\n<li><strong>Bor\u00e7 seviyeleri<\/strong>: 1,23 toplam bor\u00e7\/\u00f6zsermaye oran\u0131 izlenmeli<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Kazan\u00e7 patlamas\u0131<\/strong>: 2. \u00e7eyrek EPS 0,24 $, tahminleri %118 a\u015ft\u0131<\/li>\n<li><strong>Gelir b\u00fcy\u00fcmesi<\/strong>: Y\u0131ll\u0131k %15 art\u0131\u015fla 113 milyon $<\/li>\n<li><strong>Stratejik ortakl\u0131klar<\/strong>: NEXUS cihaz\u0131 i\u00e7in Endospan ile 25 milyon $ finansman anla\u015fmas\u0131<\/li>\n<li><strong>Sekt\u00f6r trendi<\/strong>: Kalp cihazlar\u0131 pazar\u0131 y\u0131ll\u0131k %7 b\u00fcy\u00fcyor<\/li>\n<li><strong>Teknik momentum<\/strong>: 5 May\u0131s 2025&#8217;te Alt\u0131n Y\u0131ld\u0131z Sinyali ger\u00e7ekle\u015fti<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Rahat oldu\u011funuz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcyle ba\u015flay\u0131n\u20141-2 hisse bile ba\u015flang\u0131\u00e7 i\u00e7in yeterlidir<\/li>\n<li><strong>6 Kas\u0131m&#8217;\u0131 izleyin<\/strong>: Kazan\u00e7 a\u00e7\u0131klamas\u0131 i\u00e7in uyar\u0131lar kurun ve olas\u0131 volatiliteye haz\u0131rl\u0131kl\u0131 olun<\/li>\n<li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin<\/strong>: AORT&#8217;u dengeli bir portf\u00f6y\u00fcn par\u00e7as\u0131 olarak tutun, t\u00fcm stratejiniz yapmay\u0131n<\/li>\n<li><strong>S\u00fcrekli \u00f6\u011frenin<\/strong>: Medikal cihaz sekt\u00f6r\u00fc trendlerini ve reg\u00fclasyon geli\u015fmelerini takip edin<\/li>\n<\/ol>\n<p>Esprili t\u00fcccar bilgeli\u011fi: &#8220;AORT ticareti kalp cerrahisi gibidir\u2014h\u0131zdan \u00e7ok hassasiyet \u00f6nemlidir. Kimse portf\u00f6y\u00fcnde &#8216;\u00fc\u00e7l\u00fc baypas&#8217; istemez!&#8221;<\/p>\n<h2>\u2705 Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table border=\"1\" cellpadding=\"5\" cellspacing=\"0\">\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NYSE listeli hisseleri sunan ve makul \u00fccretlere sahip oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform g\u00fcvenlik i\u00e7in kimlik do\u011frulamas\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya rahat oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;AORT&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fcz\u00fc belirleyin<\/td>\n<td>Limit emirleri giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmenize yard\u0131mc\u0131 olur<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>G\u00f6zden ge\u00e7irin ve onaylay\u0131n<\/td>\n<td>Hisse miktar\u0131 ve sipari\u015f detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, Artivion gibi hisselere eri\u015fimi daha ula\u015f\u0131labilir k\u0131lan birka\u00e7 avantaj sunar:<\/p>\n<p><strong>Sadece 5 $ minimum depozito<\/strong>\u2014daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce stratejileri minimal riskle test edebilirsiniz. Bu, AORT gibi haftal\u0131k %8 dalgalanma ya\u015fayabilen volatil hisselerde \u00f6zellikle de\u011ferlidir.<\/p>\n<p><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong>\u2014genellikle tek bir belge ile dakikalar i\u00e7inde tamamlan\u0131r. Bu sayede piyasa f\u0131rsatlar\u0131na h\u0131zl\u0131ca yan\u0131t verebilirsiniz, uzun hesap a\u00e7ma gecikmeleri olmaz.<\/p>\n<p><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong>\u2014kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100&#8217;den fazla y\u00f6ntem. Bu esneklik, k\u00e2rlar\u0131n\u0131z\u0131 size en uygun \u015fekilde \u00e7ekmenizi sa\u011flar.<\/p>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, karma\u015f\u0131k ticaret yaz\u0131l\u0131mlar\u0131nda gezinmek yerine piyasa dinamiklerini \u00f6\u011frenmeye odaklanmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Artivion: Kalp Yenili\u011finde Lider<\/h2>\n<p>Artivion, kalp ve damar cerrahisi teknolojilerine odaklanan uzmanla\u015fm\u0131\u015f bir medikal cihaz \u015firketidir. \u015eirket, aort hastal\u0131klar\u0131 tedavisinde benzersiz bir ni\u015f olu\u015fturmu\u015f, d\u00fcnya \u00e7ap\u0131nda tan\u0131nan cerrahlarla i\u015f birli\u011fi yaparak hayat de\u011fi\u015ftiren teknolojiler geli\u015ftirmi\u015ftir.<\/p>\n<p>\u015eirketin \u00fcr\u00fcn portf\u00f6y\u00fc d\u00f6rt ana kategoriyi i\u00e7erir:<\/p>\n<ul>\n<li><strong>Karma\u015f\u0131k damar onar\u0131mlar\u0131 i\u00e7in aort stent greftleri<\/strong><\/li>\n<li><strong>Azalt\u0131lm\u0131\u015f antikoag\u00fclasyon gereksinimli On-X mekanik kalp kapaklar\u0131<\/strong><\/li>\n<li><strong>Geli\u015fmi\u015f cerrahi sonu\u00e7lar i\u00e7in BioGlue gibi cerrahi s\u0131zd\u0131rmazl\u0131k malzemeleri<\/strong><\/li>\n<li><strong>Kalp rekonstr\u00fcksiyonu i\u00e7in implantabl insan dokular\u0131<\/strong><\/li>\n<\/ul>\n<p>Yakla\u015f\u0131k 2,07 milyar $ piyasa de\u011feri ile Artivion, klinik veriler, g\u00fc\u00e7l\u00fc cerrah ili\u015fkileri ve geli\u015fmekte olan pazarlardaki uygulama ile daha b\u00fcy\u00fck medikal cihaz firmalar\u0131na kar\u015f\u0131 rekabet etmektedir.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Artivion&#8217;un On-X mekanik kalp kapa\u011f\u0131, klinik faydalar\u0131 o kadar \u00f6nemli g\u00f6sterdi ki, sadece ABD&#8217;de tahmini 100 milyon $ geni\u015fleme f\u0131rsat\u0131 a\u00e7t\u0131\u2014bunun nedeni, deneme verilerinin hastalar i\u00e7in b\u00fcy\u00fck kanama riskini azaltt\u0131\u011f\u0131n\u0131 g\u00f6stermesiydi.<\/p>\n"},"faq":[{"question":"Artivion, Inc. (AORT) hisseleri nereden al\u0131nabilir?","answer":"Artivion hisseleri NYSE'de i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Artivion hisseleri i\u00e7in minimum yat\u0131r\u0131m miktar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m miktar\u0131 platforma ba\u011fl\u0131d\u0131r ancak Pocket Option gibi platformlarda sadece 5 $ depozito ile ba\u015flayabilirsiniz."},{"question":"Artivion hisselerinin riskleri nelerdir?","answer":"Reg\u00fclasyon engelleri, y\u00fcksek volatilite, k\u00e2rl\u0131l\u0131k zorluklar\u0131, rekabet bask\u0131s\u0131 ve bor\u00e7 seviyeleri ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Artivion hisseleri i\u00e7in 2025 sonras\u0131 fiyat tahmini nedir?","answer":"2025 sonunda 45-48 $, 2026'da 52-58 $, 2028'de 65-75 $ ve 2030'da 85-100+ $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayanlar Artivion hisseleri al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, \u00f6nemli kazan\u00e7 a\u00e7\u0131klamalar\u0131n\u0131 takip edin, portf\u00f6y\u00fcn\u00fcz\u00fc \u00e7e\u015fitlendirin ve sekt\u00f6rdeki geli\u015fmeleri s\u00fcrekli \u00f6\u011frenin."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Artivion, Inc. (AORT) hisseleri nereden al\u0131nabilir?","answer":"Artivion hisseleri NYSE'de i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Artivion hisseleri i\u00e7in minimum yat\u0131r\u0131m miktar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m miktar\u0131 platforma ba\u011fl\u0131d\u0131r ancak Pocket Option gibi platformlarda sadece 5 $ depozito ile ba\u015flayabilirsiniz."},{"question":"Artivion hisselerinin riskleri nelerdir?","answer":"Reg\u00fclasyon engelleri, y\u00fcksek volatilite, k\u00e2rl\u0131l\u0131k zorluklar\u0131, rekabet bask\u0131s\u0131 ve bor\u00e7 seviyeleri ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Artivion hisseleri i\u00e7in 2025 sonras\u0131 fiyat tahmini nedir?","answer":"2025 sonunda 45-48 $, 2026'da 52-58 $, 2028'de 65-75 $ ve 2030'da 85-100+ $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayanlar Artivion hisseleri al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, \u00f6nemli kazan\u00e7 a\u00e7\u0131klamalar\u0131n\u0131 takip edin, portf\u00f6y\u00fcn\u00fcz\u00fc \u00e7e\u015fitlendirin ve sekt\u00f6rdeki geli\u015fmeleri s\u00fcrekli \u00f6\u011frenin."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T10:58:39+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-30T10:58:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/\",\"name\":\"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-30T10:58:39+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/","og_locale":"tr_TR","og_type":"article","og_title":"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T10:58:39+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-30T10:58:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/","name":"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-30T10:58:39+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-artivion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Artivion, Inc. (AORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Artivion, Inc. (AORT) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":359763,"slug":"how-to-buy-artivion","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Artivion, Inc. (AORT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Artivion, Inc. (AORT)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-artivion\/"},"pt_AA":{"locale":"pt_AA","id":359762,"slug":"how-to-buy-artivion","post_title":"Como comprar a\u00e7\u00f5es da Artivion, Inc. (AORT) - Investimento em a\u00e7\u00f5es da Artivion, Inc. (AORT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-artivion\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/359768","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=359768"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/359768\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=359768"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=359768"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=359768"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}